FDA Grants Orphan Drug and Rare Pediatric Disease Designations to Ifetroban for Duchenne Muscular Dystrophy Cardiomyopathy

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced  that the United States (U.S.) Food and D...

November 07, 2024 | Thursday | News
CEO Robert Spignesi Leads Rapid Micro Biosystems to Record Q3 Revenue Growth, Achieving 24% Year-Over-Year Increase

Reports record third quarter 2024 revenue of $7.6 million, representing growth of 24%compared to the third quarter of 2023 Placed seven Growth Direct&...

November 04, 2024 | Monday | Company results
Novartis Secures FDA Accelerated Approval for Scemblix® in Newly Diagnosed CML Patients

Novartis announced that Scemblix® (asciminib) was granted accelerated approval by the US Food and Drug Administration (FDA) for adult patients wit...

October 30, 2024 | Wednesday | News
AbbVie and Gedeon Richter Forge New Agreement to Explore Treatments for Neuropsychiatric Disorders

 AbbVie (NYSE: ABBV) and Gedeon Richter Plc. ('Richter') announced a new discovery, co-development and license agreement to advance novel targets for ...

October 25, 2024 | Friday | News
Agilent Technologies Introduces Next-Generation InfinityLab LC Series with Innovative Assist Technology, Transforming Lab Automation and Efficiency

Agilent Technologies Inc. (NYSE: A) announced the release of its next generation Agilent InfinityLab LC Series portfolio, which includes the 1290 Infi...

October 22, 2024 | Tuesday | News
BOTOX® Cosmetic Gains FDA Approval for Treatment of Platysma Bands, Expanding Aesthetic Options Beyond the Face

Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the U.S. FDA approval of BOTOX® Cosmetic for temporary improvement in the appearanc...

October 21, 2024 | Monday | News
Eisai and Biogen Seek Reconsideration of Lecanemab Registration Decision in Australia

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusett...

October 17, 2024 | Thursday | News
AstraZeneca Unveils Groundbreaking Data on Vaccines and Immune Therapies at IDWeek 2024

AstraZeneca will share new data across its Vaccines & Immune Therapies portfolio at the 13th annual IDWeek in Los Angeles, California, from 16-19 ...

October 17, 2024 | Thursday | News
Avirmax Biopharma to Showcase Innovative Gene Therapy Advances at AAO 2024

Avirmax Biopharma Inc. (ABI) team will attend AAO 2024, the American Academy of Ophthalmology's annual meeting in Chicago, October 17-21, 20...

October 16, 2024 | Wednesday | News
QIAGEN Launches PAXgene Urine Liquid Biopsy Set, Advancing Non-Invasive cfDNA Collection and Stabilization

PAXgene Urine Liquid Biopsy Set with collection cup and a nucleic acid stabilizing tube enables non-invasive sample collection and direct cell-free DNA sta...

September 26, 2024 | Thursday | News
Metabolomics Diagnostics Develops PrePsia, an Innovative Test to Predict Preeclampsia Risk in Early Pregnancy

-Metabolomics Diagnostics, a deep-tech machine learning diagnostic platform developer, has developed an innovative test, PrePsia, to accurately predict t...

September 25, 2024 | Wednesday | News
Agilent Unveils Next-Generation J&W 5Q GC/MS Columns, Elevating Industry Standards in Chromatography

Agilent Technologies Inc.,  announced the release of its new Agilent J&W 5Q GC/MS Columns, representing a major advance in gas chromatogra...

August 16, 2024 | Friday | News
Calibre Scientific Acquires Acefesa, a Provider of Laboratory Consumables and Equipment in Spain

Calibre Scientific is pleased to announce the acquisition of ACEFE, S.A.U. (“ACEFESA” or the “Company”), a Barcelona-ba...

August 07, 2024 | Wednesday | News
Charles River Partners with Autobahn Labs to Accelerate Academic Drug Discovery and Development

Agreement establishes Charles River as the preferred partner for Autobahn Labs, leveraging drug discovery and development capabilities to acceler...

July 25, 2024 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close